Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
about
Efficacy of systemically administered polymyxins in mouse burn wound infection caused by multidrug-resistant Gram-negative pathogens: A proof-of-concept study.Polymyxin B in Combination with Enrofloxacin Exerts Synergistic Killing against Extensive Drug-resistant Pseudomonas aeruginosa.Proof-of-Principle Study in a Murine Lung Infection Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder Formulation.
P2860
Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Aerosolized Polymyxin B for Tr ...... a Mouse Lung Infection Model.
@en
type
label
Aerosolized Polymyxin B for Tr ...... a Mouse Lung Infection Model.
@en
prefLabel
Aerosolized Polymyxin B for Tr ...... a Mouse Lung Infection Model.
@en
P2093
P2860
P356
P1476
Aerosolized Polymyxin B for Tr ...... n a Mouse Lung Infection Model
@en
P2093
Alan Forrest
Hak-Kim Chan
Jiping Wang
Veronika Wirth
Yu-Wei Lin
P2860
P356
10.1128/AAC.00211-17
P407
P577
2017-07-25T00:00:00Z